Uscom Limited Stock: price and insider trades · Australia
Uscom Limited: what insiders have been doing
Only a handful of insider records exist for Uscom Limited, the last one from 14 May 2026, too few to describe a trend. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 24,902 of 26,897 companies
18.7
score / 100
Value5
Quality33
FCF yld-39%
Earn yld-66%
EV/EBITDA·
ROE-110%
Gross mgn84%
Net mgn-56%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended June 2024 · cache
A$0.01
Analyst consensus
Income statement
RevenueA$3.7M
Gross profitA$3.1M84% margin
EBITDA-A$1.5M-40% margin
Net income-A$2.1M-53.6% margin
Valuation
P/Book12.0x
Beta-1.32
Balance sheet & cash
Market capA$3.1M
Total debtA$989.3k
Free Cash Flow-A$1.2M
Debt / Equity12%
Profitability & ownership
ROE-110.0%
ROA-72.4%
% insiders83.0%
% institutions0.0%
Last declaration on 14 May 2026
Declarations1 total
- ShareASXISIN AU000000UCM2ASX:2924-03090103-2A1672067
1 of 1 declaration
About Uscom Limited
Uscom Limited is a company focused on developing innovative medical technologies, including cardiovascular monitoring devices. It is listed on the XASX market.
